EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its multiple sclerosis drug and for disparaging a rival company’s development of a competing me...
Read more at ABC News
-
EU Commission fines Teva $500M for trying to stop rival's multiple sclerosis drug
World - ABC News - October 31 -
Teva Fined Around $500 Million Over MS Drug Competition Concerns
Business - The Wall Street Journal - October 31 -
EU fines world’s largest generic drugmaker Teva for hindering competition
Business - Financial Times - October 31 -
Meta Fined $843 Million by EU Over Marketplace Ads Platform
Tech - The Wall Street Journal - November 14 -
EU fines Facebook parent Meta nearly 800 million euros over 'abusive' Marketplace practices
Tech - ABC News - November 14 -
EU slaps Meta with a nearly 800 million euro fine for engaging in 'abusive' Marketplace practices
World - ABC News - November 14 -
EU fines Meta over $840 million for ‘abusive practices’ favoring Facebook Marketplace
Politics - The Hill - 4 days ago
More from ABC News
-
Faulty fentanyl tests spurred NYC’s push to ban mail on Rikers Island
Health - ABC News - 19 hours ago -
Former doctor is sentenced to life in prison after conviction for sexually abusing patients
Health - ABC News - 17 hours ago -
Health advocates in Africa worry Trump will reimpose abortion 'gag rule' governing US aid
Health - ABC News - Yesterday -
What to know about Transgender Day of Remembrance and violence against trans people
Health - ABC News - 8 hours ago -
Fights over fluoride in drinking water are cropping up as political pressure mounts and scientists assess possible risks
Health - ABC News - 3 hours ago